Sandor N, Schneider A, Matola A, Barbai V, Bencze D, Hammad H
Front Immunol. 2024; 15:1135490.
PMID: 38410512
PMC: 10894998.
DOI: 10.3389/fimmu.2024.1135490.
Li L, Luan Z, Tan Y, Wang H, Yu X, Qu Z
Immunol Res. 2023; 71(6):849-859.
PMID: 37322353
PMC: 10667379.
DOI: 10.1007/s12026-023-09396-y.
Ali A, Salem M
Front Immunol. 2022; 13:1050722.
PMID: 36561762
PMC: 9763276.
DOI: 10.3389/fimmu.2022.1050722.
Daina E, Cortinovis M, Remuzzi G
Immunol Rev. 2022; 313(1):239-261.
PMID: 36369988
PMC: 10099622.
DOI: 10.1111/imr.13167.
Bansal L, Nichols E, Howsmon D, Neisen J, Bessant C, Cunningham F
Front Pharmacol. 2022; 13:855743.
PMID: 35517827
PMC: 9061988.
DOI: 10.3389/fphar.2022.855743.
A Feasibility Study on the Identification of Potential Biomarkers in Pulmonary Embolism Using Proteomic Analysis.
Granholm F, Bylund D, Shevchenko G, Lind S, Henriksson A
Clin Appl Thromb Hemost. 2022; 28:10760296221074347.
PMID: 35043712
PMC: 8796107.
DOI: 10.1177/10760296221074347.
The interaction between the complement system and hemostatic factors.
Oncul S, Afshar-Kharghan V
Curr Opin Hematol. 2020; 27(5):341-352.
PMID: 32701617
PMC: 7773221.
DOI: 10.1097/MOH.0000000000000605.
Atypical hemolytic-uremic syndrome due to complement factor I mutation.
Almalki A, Sadagah L, Qureshi M, Maghrabi H, Algain A, Alsaeed A
World J Nephrol. 2017; 6(6):243-250.
PMID: 29226095
PMC: 5714872.
DOI: 10.5527/wjn.v6.i6.243.
A case of atypical hemolytic uremic syndrome in a second renal transplant.
Zwang N, Ho B, Kanwar Y, Lewis B, Cusick M, Friedewald J
J Nephrol. 2017; 31(1):165-172.
PMID: 28224376
DOI: 10.1007/s40620-016-0373-7.
[Hemolytic kidney failure and transient ischemic attack in a 32-year-old female].
Anders R, Grohmann M, Lindner T, Bergmann C, Halbritter J
Internist (Berl). 2016; 57(10):1022-1028.
PMID: 27357251
DOI: 10.1007/s00108-016-0092-0.
Endothelial Dysfunction: The Secret Agent Driving Kidney Disease.
Johnson R, Nangaku M
J Am Soc Nephrol. 2015; 27(1):3-5.
PMID: 26038532
PMC: 4696590.
DOI: 10.1681/ASN.2015050502.
Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.
Park S, Kim G
Korean J Anesthesiol. 2014; 66(6):481-5.
PMID: 25006375
PMC: 4085272.
DOI: 10.4097/kjae.2014.66.6.481.
C3 nephritic factor associated with C3 glomerulopathy in children.
Nicolas C, Vuiblet V, Baudouin V, Macher M, Vrillon I, Biebuyck-Gouge N
Pediatr Nephrol. 2013; 29(1):85-94.
PMID: 24068526
DOI: 10.1007/s00467-013-2605-6.
The interaction between factor H and Von Willebrand factor.
Feng S, Liang X, Cruz M, Vu H, Zhou Z, Pemmaraju N
PLoS One. 2013; 8(8):e73715.
PMID: 23991205
PMC: 3753316.
DOI: 10.1371/journal.pone.0073715.
Hemolytic uremic syndrome: new developments in pathogenesis and treatment.
Boyer O, Niaudet P
Int J Nephrol. 2011; 2011:908407.
PMID: 21876803
PMC: 3159990.
DOI: 10.4061/2011/908407.
Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.
Al-Akash S, Almond P, Savell Jr V, Gharaybeh S, Hogue C
Pediatr Nephrol. 2010; 26(4):613-9.
PMID: 21125405
DOI: 10.1007/s00467-010-1708-6.
aHUS caused by complement dysregulation: new therapies on the horizon.
Waters A, Licht C
Pediatr Nephrol. 2010; 26(1):41-57.
PMID: 20556434
PMC: 2991208.
DOI: 10.1007/s00467-010-1556-4.
Atypical hemolytic uremic syndrome in the Tunisian population.
Leban N, Aloui S, Touati D, Lakhdhar R, Skhiri H, Lefranc G
Int Urol Nephrol. 2010; 43(2):559-64.
PMID: 20499172
DOI: 10.1007/s11255-010-9754-3.
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.
Saland J, Shneider B, Bromberg J, Shi P, Ward S, Magid M
Clin J Am Soc Nephrol. 2008; 4(1):201-6.
PMID: 19005013
PMC: 2615708.
DOI: 10.2215/CJN.02170508.
Complement and the atypical hemolytic uremic syndrome in children.
Loirat C, Noris M, Fremeaux-Bacchi V
Pediatr Nephrol. 2008; 23(11):1957-72.
PMID: 18594873
PMC: 6904381.
DOI: 10.1007/s00467-008-0872-4.